Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.19.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 88,251 $ 133,714
Accounts receivable 3,664 1,498
Accounts receivable due from related parties 1,316 1,316
Prepaid expenses and other current assets 4,625 3,906
Total current assets 97,856 140,434
Property, plant and equipment, net 147,193 130,580
Deferred engineering costs 75,000 69,000
Non-current restricted cash 28,040 49,875
Other non-current assets 35,923 18,659
Total assets 384,012 408,548
Current liabilities:    
Accounts payable 3,727 11,597
Accrued and other liabilities 26,414 41,173
Total current liabilities 30,141 52,770
Senior secured term loan 57,316 57,048
Other non-current liabilities 18,944 796
Total long-term liabilities 76,260 57,844
Stockholders’ equity:    
Preferred stock, $0.01 par value, 100,000,000 authorized: 6,123,782 and 6,123,782 shares outstanding, respectively 61 61
Common stock, $0.01 par value, 400,000,000 authorized: 241,863,897 and 240,655,607 shares outstanding, respectively 2,209 2,195
Additional paid-in capital 763,326 749,537
Accumulated deficit (487,985) (453,859)
Total stockholders’ equity 277,611 297,934
Total liabilities and stockholders’ equity $ 384,012 $ 408,548